The Final Screening Assessments for BAPP, Mitotane and Sclareol were published. The proposed Risk Management Approach Document for Mitotane and a notice of intent to amend the Domestic Substances List to apply the Significant New Activity provisions to BAPP were were also published for a 60-day public comment period ending on December 27, 2017.

BAPP:
Final Screening Assessment (FSAR): http://ec.gc.ca/ese-ees/default.asp?lang=En&n=6BFB0D66-1
Gazette Notice (FSAR): http://www.gazette.gc.ca/rp-pr/p1/2017/2017-10-28/html/notice-avis-eng.html#na5
Gazette Notice of intent (SNAc): http://www.gazette.gc.ca/rp-pr/p1/2017/2017-10-28/html/notice-avis-eng.html#na1

Sclareol:
FSAR: http://ec.gc.ca/ese-ees/default.asp?lang=En&n=C315BC39-1
Gazette Notice (FSAR): http://www.gazette.gc.ca/rp-pr/p1/2017/2017-10-28/html/notice-avis-eng.html#nb2

Mitotane:
FSAR: http://ec.gc.ca/ese-ees/default.asp?lang=En&n=5B5B7AFB-1
Risk Management Approach: http://ec.gc.ca/ese-ees/default.asp?lang=En&n=BFDBE0F7-1
Gazette Notice (FSAR): http://www.gazette.gc.ca/rp-pr/p1/2017/2017-10-28/html/notice-avis-eng.html#nb1